BackSeaport Therapeutics Common Stock Overview

Seaport Therapeutics Common Stock Other Current Liabilities

Seaport Therapeutics Common Stock's other current liabilities is $8.4M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$8.36M

Peer average / median

Loading

Seaport Therapeutics Common Stock Other Current Liabilities History

Loading

Seaport Therapeutics Common Stock vs. peers: Other Current Liabilities Comparison

Loading

Seaport Therapeutics Common Stock Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Seaport Therapeutics Common Stock (SPTX) FAQ

Seaport Therapeutics Common Stock (SPTX) currently reports a other current liabilities of $8.4M as of June 2026. Use the charts on this page to explore Seaport Therapeutics Common Stock's other current liabilities history and peer comparisons.

Seaport Therapeutics Common Stock reported $8.4M in other current liabilities as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $8.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Seaport Therapeutics Common Stock, and consider following SPTX for alerts when major investors trade the stock.

Seaport Therapeutics Common Stock is classified in the Healthcare sector. On other current liabilities, it currently shows $8.4M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SPTX with unrelated industries.